Cargando…

Editorial: HBV and lymphoma

Detalles Bibliográficos
Autores principales:	Gentile, Giuseppe, Arcaini, Luca, Antonelli, Guido, Martelli, Maurizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374338/ https://www.ncbi.nlm.nih.gov/pubmed/37519804 http://dx.doi.org/10.3389/fonc.2023.1236816

Ejemplares similares

HBV Reactivation in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Narrative Review
por: Gentile, Giuseppe, et al.
Publicado: (2019)

HBV Reactivation During the Treatment of Non-Hodgkin Lymphoma and Management Strategies
por: Cao, Xing, et al.
Publicado: (2021)

Editorial: Cutaneous T-Cell Lymphomas
por: Chung, Catherine G., et al.
Publicado: (2021)

Editorial: Advances in the treatment of Hodgkin lymphoma
por: Mei, Matthew, et al.
Publicado: (2023)

Editorial: Murine Models of Leukemia and Lymphoma
por: Cutucache, Christine E., et al.
Publicado: (2017)

Editorial: Cutaneous B-Cell Lymphomas
por: Alaibac, Mauro, et al.
Publicado: (2020)

Editorial: Advances in the understanding and treatment of cutaneous lymphoma
por: Bernardelli, Andrea, et al.
Publicado: (2023)

Editorial: Real World Outcomes of Lymphoma From India
por: Kumar, Lalit, et al.
Publicado: (2022)

Editorial: Advances in the treatment of primary central nervous system lymphoma
por: Qian, Liren, et al.
Publicado: (2023)

Editorial: NK/T-Cell Lymphoma: Biology, Prognostics, Prediction, and Treatment
por: El Cheikh, Jean, et al.
Publicado: (2022)

Editorial: Implementation of novel drugs and modern radiotherapy in the treatment of lymphoma patients
por: Levis, Mario, et al.
Publicado: (2023)

Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma
por: Merli, Michele, et al.
Publicado: (2016)

Case Report: Infectious prophylaxis in hematological malignancies
por: Passucci, Mauro, et al.
Publicado: (2023)

Editorial: Cancer Metabolism: Current Knowledge and Perspectives
por: Freire-de-Lima, Leonardo, et al.
Publicado: (2019)

Perioperative predictors of outcome of hepatectomy for HBV-related hepatocellular carcinoma
por: He, Ziming, et al.
Publicado: (2023)

Editorial: HBV—the naked truth?
por: Pasetto, Anna, et al.
Publicado: (2019)

Editorial: The molecular landscape and promising therapeutic targets in aggressive B-cell non-Hodgkin lymphomas
por: Witte, Hanno Maximilian, et al.
Publicado: (2023)

Editorial: Cellular and Molecular Mechanisms of Immune Checkpoint Blockers in Anti-leukemia/Lymphoma Immune Therapy
por: Ganjalikhani-Hakemi, Mazdak, et al.
Publicado: (2022)

New insights into hepatitis B virus lymphotropism: Implications for HBV-related lymphomagenesis
por: Svicher, Valentina, et al.
Publicado: (2023)

Prognostic Assessment in Patients with Indolent B-Cell Lymphomas
por: Arcaini, Luca, et al.
Publicado: (2012)

Editorial: Bone Metastases
por: Valenti, Maria Teresa, et al.
Publicado: (2021)

Whole body MRI with Diffusion Weighted Imaging versus 18F-fluorodeoxyglucose-PET/CT in the staging of lymphomas
por: Maccioni, Francesca, et al.
Publicado: (2023)

Editorial: Genomics of Lymphoproliferative Disease
por: Maura, Francesco, et al.
Publicado: (2021)

Editorial: Reviews in genitourinary oncology
por: Arcangeli, Stefano, et al.
Publicado: (2023)

Metabolomic Profiles for HBV Related Hepatocellular Carcinoma Including Alpha-Fetoproteins Positive and Negative Subtypes
por: Sun, Jianping, et al.
Publicado: (2019)

Serum soluble DR5 predicts mortality risk in patients with HBV-related hepatocellular carcinoma
por: Liang, Jiaqi, et al.
Publicado: (2022)

Editorial: Hallmark of cancer: tumor promoting inflammation
por: Roncati, Luca, et al.
Publicado: (2023)

Editorial: Radiomics in prostate cancer imaging
por: Brunese, Luca, et al.
Publicado: (2022)

Editorial: Redox and Metabolic Circuits in Cancer
por: Rizza, Salvatore, et al.
Publicado: (2018)

Editorial: Metabolic reprogramming in breast cancer
por: Scatena, Cristian, et al.
Publicado: (2022)

Editorial: Recent Advances in HBV and HCV Immunology
por: Dustin, Lynn B., et al.
Publicado: (2015)

Case Report: Discovery a Novel SARS-CoV-2 Variant in a Six-Months Long-Term Swab Positive Female Suffering From Non-Hodgkin Lymphoma
por: Capoluongo, Ettore, et al.
Publicado: (2021)

Editorial: Cholangiocarcinoma a New Multimodality Approach
por: Bronte, Fabrizio, et al.
Publicado: (2022)

Early Alpha-Fetoprotein Response Is Associated With Survival in Patients With HBV-Related Hepatocellular Carcinoma Receiving Lenvatinib
por: Liu, Bo, et al.
Publicado: (2022)

Comprehensive Analysis Identified ASF1B as an Independent Prognostic Factor for HBV-Infected Hepatocellular Carcinoma
por: Wang, Xianmo, et al.
Publicado: (2022)

Current Molecular Biology and Therapeutic Strategy Status and Prospects for circRNAs in HBV-Associated Hepatocellular Carcinoma
por: Liao, Rui, et al.
Publicado: (2021)

Editorial: Advancements in Molecular Diagnosis and Treatment of Melanoma
por: Palmieri, Giuseppe, et al.
Publicado: (2021)

Editorial: Molecular influences in therapies in ovarian cancer
por: Restaino, Stefano, et al.
Publicado: (2022)

Primary Cutaneous B-Cell Lymphomas: An Update
por: Vitiello, Paola, et al.
Publicado: (2020)

A Molecular Subtype Model for Liver HBV-Related Hepatocellular Carcinoma Patients Based on Immune-Related Genes
por: Zhang, Qiyao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sgafcok2h33bjoq978i3767l59